PEAK1, acting as a tumor promoter in colorectal cancer, is regulated by the EGFR/KRas signaling axis and miR-181d
出版年份 2018 全文链接
标题
PEAK1, acting as a tumor promoter in colorectal cancer, is regulated by the EGFR/KRas signaling axis and miR-181d
作者
关键词
-
出版物
Cell Death & Disease
Volume 9, Issue 3, Pages -
出版商
Springer Nature
发表日期
2018-02-15
DOI
10.1038/s41419-018-0320-8
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth
- (2017) Jaya Sangodkar et al. JOURNAL OF CLINICAL INVESTIGATION
- MAP4K4 is a novel MAPK/ERK pathway regulator required for lung adenocarcinoma maintenance
- (2017) Xuan Gao et al. Molecular Oncology
- Pyridoxine 5′-phosphate oxidase is a novel therapeutic target and regulated by the TGF-β signalling pathway in epithelial ovarian cancer
- (2017) Lingyun Zhang et al. Cell Death & Disease
- Pseudolaric acid B induces mitotic arrest and apoptosis in both 5-fluorouracil-sensitive and -resistant colorectal cancer cells
- (2016) Chuangyu Wen et al. CANCER LETTERS
- Identification of a PEAK1/ZEB1 signaling axis during TGFβ/fibronectin-induced EMT in breast cancer
- (2015) Megan Agajanian et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The genomic landscape of response to EGFR blockade in colorectal cancer
- (2015) Andrea Bertotti et al. NATURE
- microRNA classifiers are powerful diagnostic/prognostic tools inALK-,EGFR-, andKRAS-driven lung cancers
- (2015) Pierluigi Gasparini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PEAK1 Acts as a Molecular Switch to Regulate Context-Dependent TGFβ Responses in Breast Cancer
- (2015) Megan Agajanian et al. PLoS One
- Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2014) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- Colorectal cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Hypusine-eIF5A-PEAK1 Switch Regulates the Pathogenesis of Pancreatic Cancer
- (2014) K. Fujimura et al. CANCER RESEARCH
- MicroRNA-29c mediates initiation of gastric carcinogenesis by directly targeting ITGB1
- (2014) Tae-Su Han et al. GUT
- Primary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategies
- (2014) Simonetta M. Leto et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Involvement of Lyn and the Atypical Kinase SgK269/PEAK1 in a Basal Breast Cancer Signaling Pathway
- (2013) D. R. Croucher et al. CANCER RESEARCH
- Specific inhibition of PI3K p110δ inhibits CSF-1-induced macrophage spreading and invasive capacity
- (2013) Kellie A. Mouchemore et al. FEBS Journal
- MicroRNA-218 Inhibits Cell Migration and Invasion in Renal Cell Carcinoma through Targeting Caveolin-2 Involved in Focal Adhesion Pathway
- (2013) Takeshi Yamasaki et al. JOURNAL OF UROLOGY
- Temporal regulation of EGF signalling networks by the scaffold protein Shc1
- (2013) Yong Zheng et al. NATURE
- KRASp.G13D mutation and codon 12 mutations are not created equal in predicting clinical outcomes of cetuximab in metastatic colorectal cancer
- (2012) Chen Mao et al. CANCER
- KRas Induces a Src/PEAK1/ErbB2 Kinase Amplification Loop That Drives Metastatic Growth and Therapy Resistance in Pancreatic Cancer
- (2012) J. A. Kelber et al. CANCER RESEARCH
- Sonic hedgehog signaling pathway induces cell migration and invasion through focal adhesion kinase/AKT signaling-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9 in liver cancer
- (2012) Jing-Song Chen et al. CARCINOGENESIS
- MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis
- (2012) Keun Hur et al. GUT
- Dynamic Phosphorylation of Tyrosine 665 in Pseudopodium-enriched Atypical Kinase 1 (PEAK1) Is Essential for the Regulation of Cell Migration and Focal Adhesion Turnover
- (2012) Jeanne M. Bristow et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
- (2012) Sandra Misale et al. NATURE
- The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
- (2012) Luis A. Diaz Jr et al. NATURE
- miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expression
- (2012) W. Zhang et al. NEURO-ONCOLOGY
- MiR-181d acts as a tumor suppressor in glioma by targeting K-ras and Bcl-2
- (2011) Xie-Feng Wang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- MicroRNAs Associated with Mitogen-Activated Protein Kinase in Human Pancreatic Cancer
- (2011) Y. Ikeda et al. MOLECULAR CANCER RESEARCH
- Regulation of mRNA Translation and Stability by microRNAs
- (2010) Marc Robert Fabian et al. Annual Review of Biochemistry
- New Strategies for Treatment of KRAS Mutant Metastatic Colorectal Cancer
- (2010) H. Prenen et al. CLINICAL CANCER RESEARCH
- Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
- (2010) Wendy De Roock et al. LANCET ONCOLOGY
- Pseudopodium-enriched atypical kinase 1 regulates the cytoskeleton and cancer progression
- (2010) Y. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evaluation of Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer
- (2009) Myrddin Rees et al. ANNALS OF SURGERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search